As the in vivo microenvironment is known to induce substantial changes in the protein expression of many cancer cell lines [28, 29], this finding of the preferential expression of CASQ2 in TME in vivo suggested the involvement of this protein in tumor–stroma interactions during breast tumorigenesis. The gene discussed is CASQ2; the disease is cancer.